Steps toward clinical validation of exhaled volatile organic compound biomarkers for hypoglycemia in persons with type 1 diabetes

Steps toward clinical validation of exhaled volatile organic compound biomarkers for hypoglycemia in persons with type 1 diabetes

Abstract Persons with type 1 diabetes (T1D) must track/control their blood glucose (BG) levels to avoid hypoglycemic events (BG < 70 mg/dL), which in the most severe cases can lead to seizures or even death. Canines may lead the way toward innovative testing solutions, as they can be trained to i...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark Woollam, Paula Angarita-Rivera, Sanskar Thakur, Ali Daneshkhah, Amanda P. Siegel, Dana S. Hardin, Mangilal Agarwal
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Type 1 diabetes
Hypoglycemia
Volatile organic compounds
Exhaled breath
Gas chromatography
Mass spectrometry
Online Access:https://doi.org/10.1038/s41598-025-00284-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-00284-z

Similar Items